VAERS reports by lot

Novartis Vaccines Meningococcal lot ABXA94AA: VAERS reports

24 VAERS reports list lot ABXA94AA as a Novartis Vaccines Meningococcal vaccine, received between 2020-06-23 and 2022-09-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
12%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological3031%
General / Systemic (non-local)2020%
Injection-site / Local reaction1414%
Cardiac / Cardiovascular99%
Gastrointestinal99%
Musculoskeletal66%
Allergic / Anaphylactic55%
Respiratory44%
Dermatological (non-injection-site)11%

Where reports came from

U.S. state of the reporter, where given (top 10).

Massachusetts7
New York3
Michigan3
South Carolina2
Florida2
Georgia2
Indiana2
Iowa1
West Virginia1
New Hampshire1

Reports by month received

2020-065
2020-0710
2020-084
2020-091
2020-101
2021-061
2021-071
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.